RENAL CLEARANCE OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS

被引：16

作者：

CHAN, K ^{[1
]}

CALVEY, TN ^{[1
]}

机构：

[1] UNIV LIVERPOOL,DEPT PHARMACOL & THERAPEUT,LIVERPOOL L69 3BX,LANCASHIRE,ENGLAND

来源：

EUROPEAN NEUROLOGY | 1977年 / 16卷 / 1-6期

关键词：

D O I：

10.1159/000114882

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：69 / 72

页数：4

相关论文

共 6 条

[1] BIRTLEY RDN, 1966, BRIT J PHARMACOL, V26, P246
[2] IN-VITRO METABOLISM OF NEOSTIGMINE AND PYRIDOSTIGMINE
BURDFIEL.PA
CALVEY, TN
ROBERTS, JB
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) : 428 - 429
[3] QUANTITATIVE GAS-LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF NEOSTIGMINE AND PYRIDOSTIGMINE IN HUMAN-PLASMA
CHAN, K
WILLIAMS, NE
BATY, JD
CALVEY, TN
[J]. JOURNAL OF CHROMATOGRAPHY, 1976, 120 (02): : 349 - 358
[4] HARRIES JD, 1972, P SOC EXP BIOL MED, V140, P1148
[5] METABOLISM OF C-14-LABELED PYRIDOSTIGMINE IN MYASTHENIA GRAVIS - EVIDENCE FOR MULTIPLE METABOLITES
KORNFELD, P
SAMUELS, AJ
WOLF, RL
OSSERMAN, KE
[J]. NEUROLOGY, 1970, 20 (07) : 634 - &
[6] Studies on kidney function. I. The rate of filtration and reabsorption in the human kidney.
Rehberg, PB
[J]. BIOCHEMICAL JOURNAL, 1926, 20 (03) : 447 - +